lansoprazole has been researched along with Digestive System Diseases in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Digestive System Diseases: Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole is a proton pump inhibitor that reduces gastric acid secretion in a dose-dependent manner via inhibition of H+/K+-adenosine triphosphatase in gastric parietal cells." | 2.41 | An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. ( Bown, RL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bown, RL | 1 |
2 reviews available for lansoprazole and Digestive System Diseases
| Article | Year |
|---|---|
Lansoprazole--another proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Digestive System Diseases; Humans; Lansoprazole; Omeprazole | 1995 |
An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Digestive System Diseases; Duodenal Ulcer; Dyspepsia; Enzym | 2002 |
1 trial available for lansoprazole and Digestive System Diseases
| Article | Year |
|---|---|
Lansoprazole--another proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Digestive System Diseases; Humans; Lansoprazole; Omeprazole | 1995 |